Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSP Group Regulatory News (SSPG)

Share Price Information for SSP Group (SSPG)

Share Price is delayed by 15 minutes
Get Live Data
166.50    0.10 (0.06%)
Bid:
165.80
Ask:
166.60
Spread: 0.80 (0.483%)
Market Cap: £1.28b
SSPG Live PriceLast checked at - London Stock Exchange

Intraday SSP Group Share Chart

Exercise of over-allotment option

8 Aug 2014 16:52

RNS Number : 6955O
SSP Group PLC
08 August 2014
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

8 August 2014

SSP Group plc

Exercise of over-allotment option

SSP Group plc (the "Company") announces that, in connection with its initial public offering of ordinary shares (the "Global Offer"), Goldman Sachs International, as stabilising manager, has today exercised the over‑allotment option granted by EQT IV Limited and EQT Expansion Capital 1 Limited in respect of 34,400,712 ordinary shares in the Company (the "Over‑allotment Shares"). The Over-allotment Shares will be sold at the offer price of 210 pence per share.

 

The Company did not participate in the over-allotment option.

 

Including the exercise of the over-allotment option, the total size of the Global Offer was 263,738,787 ordinary shares, in total representing 55.5% of the 474,999,954 ordinary shares of the Company currently in issue.

Enquiries

SSP

+44 20 7543 3300

Kate Swann, Chief Executive Officer

Jonathan Davies, Chief Financial Officer

Powerscourt

+44 20 7250 1446

Rory Godson

Giles Sanderson

Rob Greening

DISCLAIMERS

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its completeness, accuracy or fairness.

Neither this announcement nor the information contained herein is for publication, distribution or release, in whole or in part, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia (other than to persons in Australia to whom an offer may be made without a disclosure document in accordance with the Chapter 6D of the Corporations Act 2001 (CTH) of Australia), Canada and Japan, including to any branch or agency of a non-U.S. person located in the United States or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction. The Global Offer and the distribution of this announcement and other information in connection with Admission and the Global Offer may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, Shares to any person in the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada or Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful. The Shares referred to herein may not be offered or sold in the United States unless registered under the US Securities Act of 1933 (the "Securities Act") or offered in a transaction exempt from, or not subject to, the registration requirements of the Securities Act. The offer and sale of Shares referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada or Japan. Subject to certain exceptions, the Shares referred to herein may not be offered or sold in Australia, Canada or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. There will be no public offer of the Shares in the United States, Australia, Canada or Japan.

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the Global Offer. It will not regard any other person as its clients in relation to the Global Offer and will not be responsible to anyone other than the Company for providing the protections afforded to its client, nor for providing advice in relation to the Global Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSGDISBGBGSI
Date   Source Headline
9th Jun 202610:27 amRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:03 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTotal Voting Rights
26th May 20265:03 pmRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:01 amRNSBoard Appointment
19th May 20267:00 amRNS2026 HALF YEAR RESULTS ANNOUNCEMENT
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
7th May 20264:54 pmRNSTR1 Notification of major interest in shares
6th May 20265:46 pmRNSDirector/PDMR Shareholding
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 202611:00 amRNSTR1 Notification of major interest in shares
27th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 202611:07 amRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20265:06 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:51 pmRNSTR1 Notification of major interest in shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 202611:01 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202610:47 amRNSTR1 Notification of major interest in shares
10th Mar 202610:47 amRNSTR1 Notification of major interest in shares
9th Mar 202612:41 pmRNSDirector/PDMR Shareholding
9th Mar 202612:41 pmRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:10 amRNSTransaction in Own Shares
5th Mar 20267:02 amRNSAppointment of Chair
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20264:05 pmRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.